1. Home
  2. SINT vs CDIO Comparison

SINT vs CDIO Comparison

Compare SINT & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SINT
  • CDIO
  • Stock Information
  • Founded
  • SINT 1996
  • CDIO 2017
  • Country
  • SINT United States
  • CDIO United States
  • Employees
  • SINT N/A
  • CDIO N/A
  • Industry
  • SINT Medical/Dental Instruments
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • SINT Health Care
  • CDIO Health Care
  • Exchange
  • SINT Nasdaq
  • CDIO Nasdaq
  • Market Cap
  • SINT 7.9M
  • CDIO 7.9M
  • IPO Year
  • SINT 2014
  • CDIO N/A
  • Fundamental
  • Price
  • SINT $3.33
  • CDIO $3.68
  • Analyst Decision
  • SINT Strong Buy
  • CDIO Buy
  • Analyst Count
  • SINT 1
  • CDIO 1
  • Target Price
  • SINT $28.00
  • CDIO $60.00
  • AVG Volume (30 Days)
  • SINT 52.3K
  • CDIO 55.2K
  • Earning Date
  • SINT 08-12-2025
  • CDIO 08-11-2025
  • Dividend Yield
  • SINT N/A
  • CDIO N/A
  • EPS Growth
  • SINT N/A
  • CDIO N/A
  • EPS
  • SINT N/A
  • CDIO N/A
  • Revenue
  • SINT $2,569,000.00
  • CDIO $19,902.00
  • Revenue This Year
  • SINT $3.26
  • CDIO $1,434.82
  • Revenue Next Year
  • SINT $21.87
  • CDIO $4,661.91
  • P/E Ratio
  • SINT N/A
  • CDIO N/A
  • Revenue Growth
  • SINT N/A
  • CDIO N/A
  • 52 Week Low
  • SINT $1.71
  • CDIO $3.22
  • 52 Week High
  • SINT $8.60
  • CDIO $53.10
  • Technical
  • Relative Strength Index (RSI)
  • SINT 62.82
  • CDIO 38.55
  • Support Level
  • SINT $3.05
  • CDIO $3.65
  • Resistance Level
  • SINT $3.29
  • CDIO $3.81
  • Average True Range (ATR)
  • SINT 0.25
  • CDIO 0.26
  • MACD
  • SINT 0.00
  • CDIO 0.16
  • Stochastic Oscillator
  • SINT 72.15
  • CDIO 46.46

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Share on Social Networks: